BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15471653)

  • 1. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
    Hu WY; Chiu TY; Cheng SY; Chen CY
    J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrition and hydration for terminal cancer patients in Taiwan.
    Chiu TY; Hu WY; Chuang RB; Chen CY
    Support Care Cancer; 2002 Nov; 10(8):630-6. PubMed ID: 12436222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
    Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
    J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyspnea and its correlates in taiwanese patients with terminal cancer.
    Chiu TY; Hu WY; Lue BH; Yao CA; Chen CY; Wakai S
    J Pain Symptom Manage; 2004 Aug; 28(2):123-32. PubMed ID: 15276193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What can family physicians contribute in palliative home care in Taiwan?
    Peng JK; Hu WY; Hung SH; Yao CA; Chen CY; Chiu TY
    Fam Pract; 2009 Aug; 26(4):287-93. PubMed ID: 19395649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of antibiotic use and survival in advanced cancer patients with infections.
    Lam PT; Chan KS; Tse CY; Leung MW
    J Pain Symptom Manage; 2005 Dec; 30(6):536-43. PubMed ID: 16376740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
    Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
    J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
    Clemens KE; Klaschik E
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths.
    Tse DM; Chan KS; Lam WM; Leu K; Lam PT
    Palliat Med; 2007 Jul; 21(5):425-33. PubMed ID: 17901102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freedom from pain--a mirage or a possibility? Experience in attempts to change laws and practices in India.
    Ghooi RB; Ghooi SR
    J Pain Palliat Care Pharmacother; 2003; 17(3-4):1-9; discussion 11-2. PubMed ID: 15022947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.
    Currow DC; Smith J; Davidson PM; Newton PJ; Agar MR; Abernethy AP
    J Pain Symptom Manage; 2010 Apr; 39(4):680-90. PubMed ID: 20413056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prescription of opioid analgesics to terminal cancer patients: impact of physicians' general attitudes and contextual factors.
    Peretti-Watel P; Bendiane MK; Obadia Y; Favre R; Lapiana JM; Moatti JP;
    Palliat Support Care; 2003 Dec; 1(4):345-52. PubMed ID: 16594224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehospital pain management: a comparison of providers' perceptions and practices.
    Hennes H; Kim MK; Pirrallo RG
    Prehosp Emerg Care; 2005; 9(1):32-9. PubMed ID: 16036825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
    Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
    J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation.
    Rietjens JA; van Zuylen L; van Veluw H; van der Wijk L; van der Heide A; van der Rijt CC
    J Pain Symptom Manage; 2008 Sep; 36(3):228-34. PubMed ID: 18411017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid use and survival at the end of life: a survey of a hospice population.
    Portenoy RK; Sibirceva U; Smout R; Horn S; Connor S; Blum RH; Spence C; Fine PG
    J Pain Symptom Manage; 2006 Dec; 32(6):532-40. PubMed ID: 17157755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
    Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
    Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good death study of elderly patients with terminal cancer in Taiwan.
    Cheng SY; Hu WY; Liu WJ; Yao CA; Chen CY; Chiu TY
    Palliat Med; 2008 Jul; 22(5):626-32. PubMed ID: 18612028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based evaluation of an intervention to improve advanced stage cancer pain management.
    Hoffmann W; Munzinger H; Horstkotte E; Greiser E
    J Pain Symptom Manage; 2004 Oct; 28(4):342-50. PubMed ID: 15471651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumors.
    Gencer D; Kästle-Larralde N; Pilz LR; Weiss A; Buchheidt D; Hochhaus A; Hofheinz RD
    Onkologie; 2009 Jul; 32(7):380-6. PubMed ID: 19556814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.